Table of Content

1 Study Coverage
1.1 Glutamate Antagonist Product Introduction
1.2 Market by Type
1.2.1 Global Glutamate Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Ionic
1.2.3 Non Ionic
1.3 Market by Application
1.3.1 Global Glutamate Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glutamate Antagonist Sales Estimates and Forecasts 2018-2029
2.2 Global Glutamate Antagonist Revenue by Region
2.2.1 Global Glutamate Antagonist Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Glutamate Antagonist Revenue by Region (2018-2024)
2.2.3 Global Glutamate Antagonist Revenue by Region (2024-2029)
2.2.4 Global Glutamate Antagonist Revenue Market Share by Region (2018-2029)
2.3 Global Glutamate Antagonist Sales Estimates and Forecasts 2018-2029
2.4 Global Glutamate Antagonist Sales by Region
2.4.1 Global Glutamate Antagonist Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Glutamate Antagonist Sales by Region (2018-2024)
2.4.3 Global Glutamate Antagonist Sales by Region (2024-2029)
2.4.4 Global Glutamate Antagonist Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Glutamate Antagonist Sales by Manufacturers
3.1.1 Global Glutamate Antagonist Sales by Manufacturers (2018-2024)
3.1.2 Global Glutamate Antagonist Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glutamate Antagonist in 2022
3.2 Global Glutamate Antagonist Revenue by Manufacturers
3.2.1 Global Glutamate Antagonist Revenue by Manufacturers (2018-2024)
3.2.2 Global Glutamate Antagonist Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Glutamate Antagonist Revenue in 2022
3.3 Global Key Players of Glutamate Antagonist, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Glutamate Antagonist Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glutamate Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glutamate Antagonist, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glutamate Antagonist, Product Offered and Application
3.8 Global Key Manufacturers of Glutamate Antagonist, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glutamate Antagonist Sales by Type
4.1.1 Global Glutamate Antagonist Historical Sales by Type (2018-2024)
4.1.2 Global Glutamate Antagonist Forecasted Sales by Type (2024-2029)
4.1.3 Global Glutamate Antagonist Sales Market Share by Type (2018-2029)
4.2 Global Glutamate Antagonist Revenue by Type
4.2.1 Global Glutamate Antagonist Historical Revenue by Type (2018-2024)
4.2.2 Global Glutamate Antagonist Forecasted Revenue by Type (2024-2029)
4.2.3 Global Glutamate Antagonist Revenue Market Share by Type (2018-2029)
4.3 Global Glutamate Antagonist Price by Type
4.3.1 Global Glutamate Antagonist Price by Type (2018-2024)
4.3.2 Global Glutamate Antagonist Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Glutamate Antagonist Sales by Application
5.1.1 Global Glutamate Antagonist Historical Sales by Application (2018-2024)
5.1.2 Global Glutamate Antagonist Forecasted Sales by Application (2024-2029)
5.1.3 Global Glutamate Antagonist Sales Market Share by Application (2018-2029)
5.2 Global Glutamate Antagonist Revenue by Application
5.2.1 Global Glutamate Antagonist Historical Revenue by Application (2018-2024)
5.2.2 Global Glutamate Antagonist Forecasted Revenue by Application (2024-2029)
5.2.3 Global Glutamate Antagonist Revenue Market Share by Application (2018-2029)
5.3 Global Glutamate Antagonist Price by Application
5.3.1 Global Glutamate Antagonist Price by Application (2018-2024)
5.3.2 Global Glutamate Antagonist Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Glutamate Antagonist Market Size by Type
6.1.1 US & Canada Glutamate Antagonist Sales by Type (2018-2029)
6.1.2 US & Canada Glutamate Antagonist Revenue by Type (2018-2029)
6.2 US & Canada Glutamate Antagonist Market Size by Application
6.2.1 US & Canada Glutamate Antagonist Sales by Application (2018-2029)
6.2.2 US & Canada Glutamate Antagonist Revenue by Application (2018-2029)
6.3 US & Canada Glutamate Antagonist Market Size by Country
6.3.1 US & Canada Glutamate Antagonist Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Glutamate Antagonist Sales by Country (2018-2029)
6.3.3 US & Canada Glutamate Antagonist Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Glutamate Antagonist Market Size by Type
7.1.1 Europe Glutamate Antagonist Sales by Type (2018-2029)
7.1.2 Europe Glutamate Antagonist Revenue by Type (2018-2029)
7.2 Europe Glutamate Antagonist Market Size by Application
7.2.1 Europe Glutamate Antagonist Sales by Application (2018-2029)
7.2.2 Europe Glutamate Antagonist Revenue by Application (2018-2029)
7.3 Europe Glutamate Antagonist Market Size by Country
7.3.1 Europe Glutamate Antagonist Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Glutamate Antagonist Sales by Country (2018-2029)
7.3.3 Europe Glutamate Antagonist Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Glutamate Antagonist Market Size
8.1.1 China Glutamate Antagonist Sales (2018-2029)
8.1.2 China Glutamate Antagonist Revenue (2018-2029)
8.2 China Glutamate Antagonist Market Size by Application
8.2.1 China Glutamate Antagonist Sales by Application (2018-2029)
8.2.2 China Glutamate Antagonist Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Glutamate Antagonist Market Size by Type
9.1.1 Asia Glutamate Antagonist Sales by Type (2018-2029)
9.1.2 Asia Glutamate Antagonist Revenue by Type (2018-2029)
9.2 Asia Glutamate Antagonist Market Size by Application
9.2.1 Asia Glutamate Antagonist Sales by Application (2018-2029)
9.2.2 Asia Glutamate Antagonist Revenue by Application (2018-2029)
9.3 Asia Glutamate Antagonist Sales by Region
9.3.1 Asia Glutamate Antagonist Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Glutamate Antagonist Revenue by Region (2018-2029)
9.3.3 Asia Glutamate Antagonist Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glutamate Antagonist Market Size by Type
10.1.1 Middle East, Africa and Latin America Glutamate Antagonist Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Glutamate Antagonist Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Glutamate Antagonist Market Size by Application
10.2.1 Middle East, Africa and Latin America Glutamate Antagonist Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Glutamate Antagonist Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Glutamate Antagonist Sales by Country
10.3.1 Middle East, Africa and Latin America Glutamate Antagonist Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Glutamate Antagonist Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Glutamate Antagonist Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Artemis Neuroscience
11.1.1 Artemis Neuroscience Company Information
11.1.2 Artemis Neuroscience Overview
11.1.3 Artemis Neuroscience Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Artemis Neuroscience Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Artemis Neuroscience Recent Developments
11.2 VistaGen Therapeutics
11.2.1 VistaGen Therapeutics Company Information
11.2.2 VistaGen Therapeutics Overview
11.2.3 VistaGen Therapeutics Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 VistaGen Therapeutics Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 VistaGen Therapeutics Recent Developments
11.3 Rottapharm Madaus
11.3.1 Rottapharm Madaus Company Information
11.3.2 Rottapharm Madaus Overview
11.3.3 Rottapharm Madaus Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Rottapharm Madaus Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Rottapharm Madaus Recent Developments
11.4 Amorsa Therapeutics
11.4.1 Amorsa Therapeutics Company Information
11.4.2 Amorsa Therapeutics Overview
11.4.3 Amorsa Therapeutics Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Amorsa Therapeutics Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amorsa Therapeutics Recent Developments
11.5 Newron Pharmaceuticals
11.5.1 Newron Pharmaceuticals Company Information
11.5.2 Newron Pharmaceuticals Overview
11.5.3 Newron Pharmaceuticals Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Newron Pharmaceuticals Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Newron Pharmaceuticals Recent Developments
11.6 Purdue Biopharma
11.6.1 Purdue Biopharma Company Information
11.6.2 Purdue Biopharma Overview
11.6.3 Purdue Biopharma Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Purdue Biopharma Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Purdue Biopharma Recent Developments
11.7 Relmada Therapeutics
11.7.1 Relmada Therapeutics Company Information
11.7.2 Relmada Therapeutics Overview
11.7.3 Relmada Therapeutics Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Relmada Therapeutics Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Relmada Therapeutics Recent Developments
11.8 BioCrea GmbH
11.8.1 BioCrea GmbH Company Information
11.8.2 BioCrea GmbH Overview
11.8.3 BioCrea GmbH Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 BioCrea GmbH Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BioCrea GmbH Recent Developments
11.9 Cerecor Inc.
11.9.1 Cerecor Inc. Company Information
11.9.2 Cerecor Inc. Overview
11.9.3 Cerecor Inc. Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Cerecor Inc. Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cerecor Inc. Recent Developments
11.10 NeurOp Inc.
11.10.1 NeurOp Inc. Company Information
11.10.2 NeurOp Inc. Overview
11.10.3 NeurOp Inc. Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 NeurOp Inc. Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NeurOp Inc. Recent Developments
11.11 UCB SA
11.11.1 UCB SA Company Information
11.11.2 UCB SA Overview
11.11.3 UCB SA Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 UCB SA Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 UCB SA Recent Developments
11.12 Novartis AG
11.12.1 Novartis AG Company Information
11.12.2 Novartis AG Overview
11.12.3 Novartis AG Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Novartis AG Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Novartis AG Recent Developments
11.13 Luc Therapeutics Inc.
11.13.1 Luc Therapeutics Inc. Company Information
11.13.2 Luc Therapeutics Inc. Overview
11.13.3 Luc Therapeutics Inc. Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Luc Therapeutics Inc. Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Luc Therapeutics Inc. Recent Developments
11.14 Evotec AG
11.14.1 Evotec AG Company Information
11.14.2 Evotec AG Overview
11.14.3 Evotec AG Glutamate Antagonist Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Evotec AG Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Evotec AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glutamate Antagonist Industry Chain Analysis
12.2 Glutamate Antagonist Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glutamate Antagonist Production Mode & Process
12.4 Glutamate Antagonist Sales and Marketing
12.4.1 Glutamate Antagonist Sales Channels
12.4.2 Glutamate Antagonist Distributors
12.5 Glutamate Antagonist Customers
13 Market Dynamics
13.1 Glutamate Antagonist Industry Trends
13.2 Glutamate Antagonist Market Drivers
13.3 Glutamate Antagonist Market Challenges
13.4 Glutamate Antagonist Market Restraints
14 Key Findings in The Global Glutamate Antagonist Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Glutamate Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Ionic
Table 3. Major Manufacturers of Non Ionic
Table 4. Global Glutamate Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Glutamate Antagonist Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Glutamate Antagonist Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Glutamate Antagonist Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Glutamate Antagonist Revenue Market Share by Region (2018-2024)
Table 9. Global Glutamate Antagonist Revenue Market Share by Region (2024-2029)
Table 10. Global Glutamate Antagonist Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Glutamate Antagonist Sales by Region (2018-2024) & (K Units)
Table 12. Global Glutamate Antagonist Sales by Region (2024-2029) & (K Units)
Table 13. Global Glutamate Antagonist Sales Market Share by Region (2018-2024)
Table 14. Global Glutamate Antagonist Sales Market Share by Region (2024-2029)
Table 15. Global Glutamate Antagonist Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Glutamate Antagonist Sales Share by Manufacturers (2018-2024)
Table 17. Global Glutamate Antagonist Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Glutamate Antagonist Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Glutamate Antagonist, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Glutamate Antagonist Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Glutamate Antagonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Glutamate Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Antagonist as of 2022)
Table 23. Global Key Manufacturers of Glutamate Antagonist, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Glutamate Antagonist, Product Offered and Application
Table 25. Global Key Manufacturers of Glutamate Antagonist, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 28. Global Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 29. Global Glutamate Antagonist Sales Share by Type (2018-2024)
Table 30. Global Glutamate Antagonist Sales Share by Type (2024-2029)
Table 31. Global Glutamate Antagonist Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Glutamate Antagonist Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Glutamate Antagonist Revenue Share by Type (2018-2024)
Table 34. Global Glutamate Antagonist Revenue Share by Type (2024-2029)
Table 35. Glutamate Antagonist Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Glutamate Antagonist Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 38. Global Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 39. Global Glutamate Antagonist Sales Share by Application (2018-2024)
Table 40. Global Glutamate Antagonist Sales Share by Application (2024-2029)
Table 41. Global Glutamate Antagonist Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Glutamate Antagonist Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Glutamate Antagonist Revenue Share by Application (2018-2024)
Table 44. Global Glutamate Antagonist Revenue Share by Application (2024-2029)
Table 45. Glutamate Antagonist Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Glutamate Antagonist Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Glutamate Antagonist Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Glutamate Antagonist Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Glutamate Antagonist Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Glutamate Antagonist Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Glutamate Antagonist Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Glutamate Antagonist Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Glutamate Antagonist Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 60. Europe Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 61. Europe Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 62. Europe Glutamate Antagonist Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Glutamate Antagonist Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 65. Europe Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 66. Europe Glutamate Antagonist Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Glutamate Antagonist Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Glutamate Antagonist Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Glutamate Antagonist Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Glutamate Antagonist Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 72. Europe Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 73. China Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 74. China Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 75. China Glutamate Antagonist Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Glutamate Antagonist Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 78. China Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 79. China Glutamate Antagonist Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Glutamate Antagonist Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 82. Asia Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 83. Asia Glutamate Antagonist Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Glutamate Antagonist Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 86. Asia Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 87. Asia Glutamate Antagonist Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Glutamate Antagonist Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Glutamate Antagonist Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Glutamate Antagonist Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Glutamate Antagonist Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Glutamate Antagonist Sales by Region (2018-2024) & (K Units)
Table 93. Asia Glutamate Antagonist Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Glutamate Antagonist Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Glutamate Antagonist Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Glutamate Antagonist Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Glutamate Antagonist Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Glutamate Antagonist Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Glutamate Antagonist Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Glutamate Antagonist Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Glutamate Antagonist Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Glutamate Antagonist Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Glutamate Antagonist Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Glutamate Antagonist Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Glutamate Antagonist Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Glutamate Antagonist Sales by Country (2024-2029) & (K Units)
Table 107. Artemis Neuroscience Company Information
Table 108. Artemis Neuroscience Description and Major Businesses
Table 109. Artemis Neuroscience Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Artemis Neuroscience Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Artemis Neuroscience Recent Developments
Table 112. VistaGen Therapeutics Company Information
Table 113. VistaGen Therapeutics Description and Major Businesses
Table 114. VistaGen Therapeutics Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. VistaGen Therapeutics Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. VistaGen Therapeutics Recent Developments
Table 117. Rottapharm Madaus Company Information
Table 118. Rottapharm Madaus Description and Major Businesses
Table 119. Rottapharm Madaus Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Rottapharm Madaus Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Rottapharm Madaus Recent Developments
Table 122. Amorsa Therapeutics Company Information
Table 123. Amorsa Therapeutics Description and Major Businesses
Table 124. Amorsa Therapeutics Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Amorsa Therapeutics Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Amorsa Therapeutics Recent Developments
Table 127. Newron Pharmaceuticals Company Information
Table 128. Newron Pharmaceuticals Description and Major Businesses
Table 129. Newron Pharmaceuticals Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Newron Pharmaceuticals Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Newron Pharmaceuticals Recent Developments
Table 132. Purdue Biopharma Company Information
Table 133. Purdue Biopharma Description and Major Businesses
Table 134. Purdue Biopharma Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Purdue Biopharma Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Purdue Biopharma Recent Developments
Table 137. Relmada Therapeutics Company Information
Table 138. Relmada Therapeutics Description and Major Businesses
Table 139. Relmada Therapeutics Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Relmada Therapeutics Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Relmada Therapeutics Recent Developments
Table 142. BioCrea GmbH Company Information
Table 143. BioCrea GmbH Description and Major Businesses
Table 144. BioCrea GmbH Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. BioCrea GmbH Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. BioCrea GmbH Recent Developments
Table 147. Cerecor Inc. Company Information
Table 148. Cerecor Inc. Description and Major Businesses
Table 149. Cerecor Inc. Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Cerecor Inc. Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Cerecor Inc. Recent Developments
Table 152. NeurOp Inc. Company Information
Table 153. NeurOp Inc. Description and Major Businesses
Table 154. NeurOp Inc. Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. NeurOp Inc. Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. NeurOp Inc. Recent Developments
Table 157. UCB SA Company Information
Table 158. UCB SA Description and Major Businesses
Table 159. UCB SA Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. UCB SA Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. UCB SA Recent Developments
Table 162. Novartis AG Company Information
Table 163. Novartis AG Description and Major Businesses
Table 164. Novartis AG Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Novartis AG Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Novartis AG Recent Developments
Table 167. Luc Therapeutics Inc. Company Information
Table 168. Luc Therapeutics Inc. Description and Major Businesses
Table 169. Luc Therapeutics Inc. Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Luc Therapeutics Inc. Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Luc Therapeutics Inc. Recent Developments
Table 172. Evotec AG Company Information
Table 173. Evotec AG Description and Major Businesses
Table 174. Evotec AG Glutamate Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Evotec AG Glutamate Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Evotec AG Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Glutamate Antagonist Distributors List
Table 180. Glutamate Antagonist Customers List
Table 181. Glutamate Antagonist Market Trends
Table 182. Glutamate Antagonist Market Drivers
Table 183. Glutamate Antagonist Market Challenges
Table 184. Glutamate Antagonist Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Glutamate Antagonist Product Picture
Figure 2. Global Glutamate Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Glutamate Antagonist Market Share by Type in 2022 & 2029
Figure 4. Ionic Product Picture
Figure 5. Non Ionic Product Picture
Figure 6. Global Glutamate Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Glutamate Antagonist Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Laboratory
Figure 11. Others
Figure 12. Glutamate Antagonist Report Years Considered
Figure 13. Global Glutamate Antagonist Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Glutamate Antagonist Revenue 2018-2029 (US$ Million)
Figure 15. Global Glutamate Antagonist Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Glutamate Antagonist Revenue Market Share by Region (2018-2029)
Figure 17. Global Glutamate Antagonist Sales 2018-2029 ((K Units)
Figure 18. Global Glutamate Antagonist Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Glutamate Antagonist Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Glutamate Antagonist Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Glutamate Antagonist Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Glutamate Antagonist Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Glutamate Antagonist Sales YoY (2018-2029) & (K Units)
Figure 24. China Glutamate Antagonist Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Glutamate Antagonist Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Glutamate Antagonist Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Glutamate Antagonist Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Glutamate Antagonist Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Glutamate Antagonist Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Glutamate Antagonist in the World: Market Share by Glutamate Antagonist Revenue in 2022
Figure 31. Global Glutamate Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Glutamate Antagonist Sales Market Share by Type (2018-2029)
Figure 33. Global Glutamate Antagonist Revenue Market Share by Type (2018-2029)
Figure 34. Global Glutamate Antagonist Sales Market Share by Application (2018-2029)
Figure 35. Global Glutamate Antagonist Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Glutamate Antagonist Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Glutamate Antagonist Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Glutamate Antagonist Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Glutamate Antagonist Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Glutamate Antagonist Revenue Share by Country (2018-2029)
Figure 41. US & Canada Glutamate Antagonist Sales Share by Country (2018-2029)
Figure 42. U.S. Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Glutamate Antagonist Sales Market Share by Type (2018-2029)
Figure 45. Europe Glutamate Antagonist Revenue Market Share by Type (2018-2029)
Figure 46. Europe Glutamate Antagonist Sales Market Share by Application (2018-2029)
Figure 47. Europe Glutamate Antagonist Revenue Market Share by Application (2018-2029)
Figure 48. Europe Glutamate Antagonist Revenue Share by Country (2018-2029)
Figure 49. Europe Glutamate Antagonist Sales Share by Country (2018-2029)
Figure 50. Germany Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 51. France Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 55. China Glutamate Antagonist Sales Market Share by Type (2018-2029)
Figure 56. China Glutamate Antagonist Revenue Market Share by Type (2018-2029)
Figure 57. China Glutamate Antagonist Sales Market Share by Application (2018-2029)
Figure 58. China Glutamate Antagonist Revenue Market Share by Application (2018-2029)
Figure 59. Asia Glutamate Antagonist Sales Market Share by Type (2018-2029)
Figure 60. Asia Glutamate Antagonist Revenue Market Share by Type (2018-2029)
Figure 61. Asia Glutamate Antagonist Sales Market Share by Application (2018-2029)
Figure 62. Asia Glutamate Antagonist Revenue Market Share by Application (2018-2029)
Figure 63. Asia Glutamate Antagonist Revenue Share by Region (2018-2029)
Figure 64. Asia Glutamate Antagonist Sales Share by Region (2018-2029)
Figure 65. Japan Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 69. India Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Glutamate Antagonist Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Glutamate Antagonist Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Glutamate Antagonist Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Glutamate Antagonist Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Glutamate Antagonist Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Glutamate Antagonist Sales Share by Country (2018-2029)
Figure 76. Brazil Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Glutamate Antagonist Revenue (2018-2029) & (US$ Million)
Figure 81. Glutamate Antagonist Value Chain
Figure 82. Glutamate Antagonist Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed